BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15774801)

  • 1. Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer?
    Fiorentini G; Rossi S; Bernardeschi P; Cantore M; Guadagni S
    J Clin Oncol; 2005 Mar; 23(9):2105; author reply 2106. PubMed ID: 15774801
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Gonen M; Stockman J; Blumgart L; Sperber D; Hummer A; Fong Y
    J Clin Oncol; 2003 Sep; 21(17):3303-9. PubMed ID: 12947066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer.
    Kemeny N
    J Natl Compr Canc Netw; 2010 May; 8(5):507-9. PubMed ID: 20495081
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic metastases of colorectal cancer: locoregional intra-arterial treatment.
    Pasetto LM; Merenda R; Pilati P; Sinigaglia G; Monfardini S
    Anticancer Res; 2006; 26(6C):4785-92. PubMed ID: 17214342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Venook AP; Althaus B; Warren RS
    N Engl J Med; 2000 May; 342(20):1524; author reply 1526-7. PubMed ID: 10819648
    [No Abstract]   [Full Text] [Related]  

  • 6. A role for hepatic-directed chemotherapy in colorectal liver metastases.
    Ensminger WD
    J Clin Oncol; 2005 Aug; 23(22):4815-7. PubMed ID: 16009957
    [No Abstract]   [Full Text] [Related]  

  • 7. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
    Allard MA; Malka D
    J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: a phase II trial].
    Strobel O; Büchler MW
    Chirurg; 2014 Jul; 85(7):641. PubMed ID: 24934110
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Atkins CD
    N Engl J Med; 2000 May; 342(20):1524-5; author reply 1526-7. PubMed ID: 10819649
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases.
    White RR; Schwartz LH; Munoz JA; Raggio G; Jarnagin WR; Fong Y; D'Angelica MI; Kemeny NE
    J Surg Oncol; 2008 Jun; 97(7):601-4. PubMed ID: 18449915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.
    Kemeny N; Conti JA; Cohen A; Campana P; Huang Y; Shi WJ; Botet J; Pulliam S; Bertino JR
    J Clin Oncol; 1994 Nov; 12(11):2288-95. PubMed ID: 7964942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.
    Kemeny N; Gonen M; Sullivan D; Schwartz L; Benedetti F; Saltz L; Stockman J; Fong Y; Jarnagin W; Bertino J; Tong W; Paty P
    J Clin Oncol; 2001 May; 19(10):2687-95. PubMed ID: 11352961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Lorenz M; Hochmuth K; Müller HH
    N Engl J Med; 2000 May; 342(20):1525-6; author reply 1526-7. PubMed ID: 10819651
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic arterial infusion chemotherapy for liver metastases from colorectal cancer].
    Arai Y; Matsueda K; Inaba Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2193-200. PubMed ID: 11142162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery infusion for liver metastases from colorectal cancer.
    Bonetti A
    Lancet; 2003 Feb; 361(9355):358-9. PubMed ID: 12573366
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y
    J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic metastases from colorectal cancer.
    Kemeny MM
    Tumori; 1997; 83(1 Suppl):S26-7. PubMed ID: 9154064
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
    Power DG; Kemeny NE
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.
    Bilchik AJ; Wood TF; Chawla SP; Rose DM; Chung MH; Stern SS; Foshag LJ; Ramming KP
    Clin Colorectal Cancer; 2001 May; 1(1):36-42. PubMed ID: 12445377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.